ProCE Banner Activity

探索更多HIV暴露前预防(PrEP)的用药方案

Conference Coverage
Clinical Thought

自从8年前推出每日口服恩曲他滨/替诺福韦(FTC/TDF) 的PrEP方案以来,出现了诸多新方案,并且有些研究策略不需要每天口服给药,其鼓舞人心的新数据表明,高效的HIV预防方法将持续扩展下去。接下来是我对2020年国际艾滋病大会(在线)公布的新PrEP数据的看法。

Released: September 02, 2020

Expiration: September 01, 2021

No longer available for credit.

Share

Faculty

Eric S. Daar

Eric S. Daar, MD

Chief, Division of HIV Medicine
Harbor-UCLA Medical Center
Professor of Medicine
David Geffen School of Medicine at UCLA
Los Angeles, California

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

教育拨款提供方:

Gilead

Merck Sharp & Dohme Corp.

ViiV Healthcare

Partners

AIDS 2020

ProCE Banner

IAS 2018

ProCE Banner

Faculty Disclosure

Primary Author

Eric S. Daar, MD

Chief, Division of HIV Medicine
Harbor-UCLA Medical Center
Professor of Medicine
David Geffen School of Medicine at UCLA
Los Angeles, California

医学博士Eric S. Daar披露,他之前从基因技术(Genentech),吉利德科学和ViiV Healthcare获得过咨询费,并从吉利德科学、默克和ViiV Healthcare获得过研究资金。